Clinical Trials in San Francisco

Showing 6521-6540 of 12,991 trials

Safety and Effectiveness of Lopinavir/Ritonavir in HIV Infected Infants

NCT00038480

The purpose of this study is to find out if the drug lopinavir/ritonavir (LPV/RTV) is safe and well tolerated in HIV infected infants. This study will also determine the most effective dose of LPV/RTV for infants.

HIV Infections

National Institute of Allergy and Infectious Diseases (NIAID)31 participants

Oakland, California, United States • San Francisco, California, United States • Aurora, Colorado, United States +14 more locations

COMPLETEDPhase 1/2< 1 mile

Vaccine (ALVAC-HIV vCP1452) Use and Intermittent Withdrawal of Anti-HIV Drugs in Patients With HIV

NCT00011011

Long-term control of HIV depends on improvement in an individual's immune system. The purpose of this study is to see if either stopping anti-HIV drugs for short periods of time and/or adding a vaccine to the anti-HIV drugs being taken will help to better control HIV infection. The study will test whether these treatment approaches are safe. The HIV vaccine in this study has been tested in people who did not have HIV infection and improved the way their immune system worked. This study will evaluate whether these same immune system changes happen in people with HIV, and, if such changes do occur, assess whether these changes help to improve control of HIV in these patients.

HIV Infections

National Institute of Allergy and Infectious Diseases (NIAID)94 participantsStarted Feb 2001

Birmingham, Alabama, United States • Los Angeles, California, United States • San Francisco, California, United States +13 more locations

Safety and Effectiveness of Lopinavir/Ritonavir in HIV Infected Infants

Vaccine (ALVAC-HIV vCP1452) Use and Intermittent Withdrawal of Anti-HIV Drugs in Patients With HIV

Find Trials by Condition in San Francisco

Testosterone for HIV-Positive Men With Reduced Serum Testosterone Levels and Abdominal Fat

Dual Versus Triple Protease Inhibitor Combinations, Including Ritonavir, in HIV Infected People

Safety and Effectiveness of the Oral HIV Entry Inhibitor Vicriviroc in HIV Infected Patients

Combination Treatment With and Without Protease Inhibitors for Women Who Begin Therapy for HIV Infection During Pregnancy

The Safety and Effectiveness of Hydroxyurea and ddI Used Individually or Together in HIV-Infected Patients

A Study of Megestrol Acetate Alone or in Combination With Testosterone Enanthate Drug in the Treatment of HIV-Associated Weight Loss

The Effects of Anti-HIV Drugs in HIV-Infected Patients Who Do Not Have AIDS

A Study of Dextran Sulfate in HIV-Infected Patients and in Patients With AIDS or AIDS Related Complex (ARC)

Safety and Tolerance of Indinavir Plus Ritonavir in HIV-Positive Patients Failing Therapy With Amprenavir, Nelfinavir, or Saquinavir

The Effectiveness of Three Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Never Used Anti-HIV Drugs

A Study of DAPD Alone Versus DAPD Plus MMF for Treatment of HIV Infection

Drug Interactions of Amprenavir and Efavirenz, in Combination With a Second Protease Inhibitor, in HIV-Negative Volunteers

Safety, Tolerability, and Blood Levels of Ritonavir-Boosted Atazanavir and Rifampin When Taken Together in HIV Uninfected Adults

Stem Cell Transplantation in Individuals With Multiple Myeloma (BMT CTN 0102)

A Study of Zidovudine in HIV-Infected Patients Who Have Hemophilia

Monovalent H5N1 Vaccine GSK1557484A in Children 6 Months to < 18 Years of Age

A Study of the Effectiveness of an HIV Vaccine (ALVAC vCP205) to Boost Immune Functions in HIV-Negative Volunteers Who Have Already Received an HIV Vaccine

A Study to Evaluate the Ability of TNFR:Fc to Decrease the Amount of IL-6 (Interleukin-6) and TNF-alpha (Tumor Necrosis Factor) in HIV-Infected Patients